A summary of head-to-head comparisons of patient (pt) risk classifications by the 21-gene Recurrence Score® (RS) assay and other genomic assays for early breast cancer (EBC). (March 2017) - Varga, Z.; McCullough, D.; Lau, A.; Stöppler, M.; Baehner, F.L.; Seidman, A.D.